ID   AHV_ACTSK               Reviewed;         160 AA.
AC   Q9KWN0;
DT   15-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   25-MAY-2022, entry version 79.
DE   RecName: Full=Actinohivin;
DE   Flags: Precursor;
GN   Name=ath;
OS   Actinomycete sp. (strain K97-0003).
OC   Bacteria; Actinobacteria; Actinomycetales.
OX   NCBI_TaxID=237531 {ECO:0000305};
RN   [1] {ECO:0000312|EMBL:BAA97578.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11243871; DOI=10.1006/bbrc.2001.4496;
RA   Inokoshi J., Chiba H., Asanuma S., Takahashi A., Omura S., Tanaka H.;
RT   "Molecular cloning of actinohivin, a novel anti-HIV protein from an
RT   actinomycete, and its expression in Escherichia coli.";
RL   Biochem. Biophys. Res. Commun. 281:1261-1265(2001).
RN   [2] {ECO:0000305}
RP   PROTEIN SEQUENCE OF 47-160, FUNCTION, AND MASS SPECTROMETRY.
RX   PubMed=11401502; DOI=10.1006/bbrc.2001.4495;
RA   Chiba H., Inokoshi J., Okamoto M., Asanuma S., Matsuzaki K., Iwama M.,
RA   Mizumoto K., Tanaka H., Oheda M., Fujita K., Nakashima H., Shinose M.,
RA   Takahashi Y., Omura S.;
RT   "Actinohivin, a novel anti-HIV protein from an actinomycete that inhibits
RT   syncytium formation: isolation, characterization, and biological
RT   activities.";
RL   Biochem. Biophys. Res. Commun. 282:595-601(2001).
RN   [3]
RP   INTERACTION WITH HIV-1 GP120 AND SIV GP130.
RX   PubMed=15003531; DOI=10.1016/j.bbrc.2004.02.036;
RA   Chiba H., Inokoshi J., Nakashima H., Omura S., Tanaka H.;
RT   "Actinohivin, a novel anti-human immunodeficiency virus protein from an
RT   actinomycete, inhibits viral entry to cells by binding high-mannose type
RT   sugar chains of gp120.";
RL   Biochem. Biophys. Res. Commun. 316:203-210(2004).
RN   [4]
RP   MUTAGENESIS OF ILE-51; GLN-79; GLN-117 AND GLN-155.
RX   PubMed=15850563; DOI=10.1016/j.abb.2005.03.017;
RA   Takahashi A., Inokoshi J., Chiba H., Omura S., Tanaka H.;
RT   "Essential regions for antiviral activities of actinohivin, a sugar-binding
RT   anti-human immunodeficiency virus protein from an actinomycete.";
RL   Arch. Biochem. Biophys. 437:233-240(2005).
CC   -!- SUBUNIT: Interacts with HIV gp120 and SIV gp130.
CC       {ECO:0000269|PubMed:15003531}.
CC   -!- INTERACTION:
CC       Q9KWN0; Q75760: env; Xeno; NbExp=2; IntAct=EBI-8453511, EBI-8453491;
CC   -!- MASS SPECTROMETRY: Mass=12520.3; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:11401502};
CC   -!- MISCELLANEOUS: Anti-HIV protein that inhibits virus membrane fusion.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB032371; BAA97578.1; -; Genomic_DNA.
DR   PIR; JC7622; JC7622.
DR   PDB; 3A07; X-ray; 1.19 A; A/B=43-160.
DR   PDB; 4DEN; X-ray; 1.60 A; A=47-160.
DR   PDB; 4END; X-ray; 1.90 A; A=47-160.
DR   PDB; 4G1R; X-ray; 1.57 A; A/C=47-160.
DR   PDB; 4P6A; X-ray; 1.40 A; A=47-160.
DR   PDBsum; 3A07; -.
DR   PDBsum; 4DEN; -.
DR   PDBsum; 4END; -.
DR   PDBsum; 4G1R; -.
DR   PDBsum; 4P6A; -.
DR   AlphaFoldDB; Q9KWN0; -.
DR   SMR; Q9KWN0; -.
DR   IntAct; Q9KWN0; 1.
DR   MINT; Q9KWN0; -.
DR   CAZy; CBM13; Carbohydrate-Binding Module Family 13.
DR   UniLectin; Q9KWN0; -.
DR   EvolutionaryTrace; Q9KWN0; -.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0050688; P:regulation of defense response to virus; IEA:UniProtKB-KW.
DR   CDD; cd00161; RICIN; 1.
DR   InterPro; IPR035992; Ricin_B-like_lectins.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF00652; Ricin_B_lectin; 1.
DR   SMART; SM00458; RICIN; 1.
DR   SUPFAM; SSF50370; SSF50370; 1.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antiviral protein; Direct protein sequencing; Lectin; Repeat;
KW   Signal.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000255"
FT   PROPEP          27..46
FT                   /evidence="ECO:0000255, ECO:0000269|PubMed:11243871,
FT                   ECO:0000269|PubMed:11401502"
FT                   /id="PRO_0000020653"
FT   CHAIN           47..160
FT                   /note="Actinohivin"
FT                   /id="PRO_0000020654"
FT   DOMAIN          45..160
FT                   /note="Ricin B-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   REPEAT          47..84
FT                   /note="1"
FT                   /evidence="ECO:0000303|PubMed:11401502"
FT   REPEAT          85..122
FT                   /note="2"
FT                   /evidence="ECO:0000303|PubMed:11401502"
FT   REPEAT          123..160
FT                   /note="3"
FT                   /evidence="ECO:0000303|PubMed:11401502"
FT   REGION          47..160
FT                   /note="3 X 38 AA tandem repeats"
FT   MUTAGEN         51
FT                   /note="I->A: Partial loss of HIV fusion inhibition."
FT                   /evidence="ECO:0000269|PubMed:15850563"
FT   MUTAGEN         79
FT                   /note="Q->A: Partial loss of HIV fusion inhibition."
FT                   /evidence="ECO:0000269|PubMed:15850563"
FT   MUTAGEN         117
FT                   /note="Q->A: Partial loss of HIV fusion inhibition."
FT                   /evidence="ECO:0000269|PubMed:15850563"
FT   MUTAGEN         155
FT                   /note="Q->A: Complete loss of HIV fusion inhibition."
FT                   /evidence="ECO:0000269|PubMed:15850563"
FT   STRAND          46..49
FT                   /evidence="ECO:0007829|PDB:3A07"
FT   STRAND          51..53
FT                   /evidence="ECO:0007829|PDB:3A07"
FT   TURN            54..56
FT                   /evidence="ECO:0007829|PDB:3A07"
FT   STRAND          59..62
FT                   /evidence="ECO:0007829|PDB:3A07"
FT   STRAND          68..71
FT                   /evidence="ECO:0007829|PDB:3A07"
FT   HELIX           77..79
FT                   /evidence="ECO:0007829|PDB:3A07"
FT   STRAND          81..83
FT                   /evidence="ECO:0007829|PDB:3A07"
FT   STRAND          85..87
FT                   /evidence="ECO:0007829|PDB:3A07"
FT   TURN            92..94
FT                   /evidence="ECO:0007829|PDB:3A07"
FT   STRAND          97..100
FT                   /evidence="ECO:0007829|PDB:3A07"
FT   STRAND          105..109
FT                   /evidence="ECO:0007829|PDB:3A07"
FT   HELIX           115..117
FT                   /evidence="ECO:0007829|PDB:3A07"
FT   STRAND          119..121
FT                   /evidence="ECO:0007829|PDB:3A07"
FT   STRAND          127..129
FT                   /evidence="ECO:0007829|PDB:3A07"
FT   TURN            130..132
FT                   /evidence="ECO:0007829|PDB:3A07"
FT   STRAND          135..138
FT                   /evidence="ECO:0007829|PDB:3A07"
FT   STRAND          144..147
FT                   /evidence="ECO:0007829|PDB:3A07"
FT   HELIX           153..155
FT                   /evidence="ECO:0007829|PDB:3A07"
FT   STRAND          157..159
FT                   /evidence="ECO:0007829|PDB:3A07"
SQ   SEQUENCE   160 AA;  16870 MW;  37F269BD16106240 CRC64;
     MNTLTKLTIG AVALTGSFLA AAPASAAPAA DTTASPALGS QVSAQFASVT IRNAQTGRLL
     DSNYNGNVYT LPANGGNYQR WTGPGDGTVR NAQTGRCLDS NYDGAVYTLP CNGGSYQKWL
     FYSNGYIQNV ETGRVLDSNY NGNVYTLPAN GGNYQKWYTG
//
